Combipatch (estradiol/norethindrone Acetate Transdermal System) Patch, Extended Release
Product Images NDC 68968-0525

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Combipatch (estradiol/norethindrone Acetate Transdermal System) (NDC 68968-0525). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Noven Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Combipatch Figure 1)

Estradiol Norethindrone Acetate is a medication that combines two hormones: estradiol and norethindrone acetate. It is used for hormone replacement therapy in women who have reached menopause. This medication can help relieve symptoms of menopause, such as hot flashes and vaginal dryness. It may also help prevent osteoporosis. The specific use and dosage of Estradiol Norethindrone Acetate should be determined by a healthcare provider.*

FDA Label Image

Combipatch Figure 10

FDA Label Image

Combipatch Figure 11

FDA Label Image

Layer (Combipatch Figure 2)

FDA Label Image

Chart (Combipatch Figure 3)

FDA Label Image

Figure A (Combipatch Figure 4)

FDA Label Image

Figure B (Combipatch Figure 5)

FDA Label Image

Figure C,d (Combipatch Figure 6)

FDA Label Image

Figure E (Combipatch Figure 7)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.